Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Sudden Cardiac and Sudden Unexpected Death Related to Antipsychotics: A Meta-analysis of Observational Studies

Lookup NU author(s): Professor Simon ThomasORCiD

Downloads


Licence

This is the authors' accepted manuscript of an article that has been published in its final definitive form by Wiley-Blackwell Publishing Ltd., 2016.

For re-use rights please refer to the publisher's terms and conditions.


Abstract

To estimate the risk of sudden cardiac death (SCD) or sudden unexpected death (SUD) related to individual antipsychotics, a meta-analysis of observational studies was performed. Adjusted odds ratio (OR) of SCD/SUD with 95% confidence intervals (CI) were extracted and pooled; heterogeneity was studied using Q statistic and I-2 index, and its potential causes (e.g., hERG blockade potency) explored using meta-regression. Two cohort (740,306 person-years) and four case-control (2,557 cases; 17,670 controls) studies, investigating nine antipsychotics, were included. Compared with nonusers, the risk was increased for quetiapine (OR = 1.72, 95% CI: 1.33-2.23), olanzapine (OR = 2.04, 1.52-2.74), risperidone (OR = 3.04, 2.39-3.86), haloperidol (OR = 2.97, 1.59-5.54), clozapine (OR = 3.67, 1.94-6.94), and thioridazine (OR = 4.58, 2.09-10.05). Heterogeneity was found (Q = 20.0, P = 0.01; I-2 = 60.0%), and the increasing mean hERG blockade potency (P = 0.01) accounted for 43% of this. The SCD/SUD risk differed between individual antipsychotics, and mean hERG blockade potency could be an explanatory factor. This should be considered when initiating antipsychotic treatment.


Publication metadata

Author(s): Salvo F, Pariente A, Shakir S, Robinson P, Arnaud M, Thomas SHL, Raschi E, Fourrier-Reglat A, Moore N, Sturkenboom M, Hazell L, Investigators Aritmo Consortium

Publication type: Article

Publication status: Published

Journal: Clinical Pharmacology & Therapeutics

Year: 2016

Volume: 99

Issue: 3

Pages: 306-314

Print publication date: 01/03/2016

Online publication date: 20/11/2015

Acceptance date: 09/08/2015

Date deposited: 03/06/2016

ISSN (print): 0009-9236

ISSN (electronic): 1532-6535

Publisher: Wiley-Blackwell Publishing Ltd.

URL: http://dx.doi.org/10.1002/cpt.250

DOI: 10.1002/cpt.250


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
241679European Community's Seventh Framework Program: ARITMO project

Share